Are you seeking to improve the production, economics, and overall derisking the development of your therapeutics?
We ask you to leverage our PET platform capabilities with us, that includes rapid candidate selection, high success rates for expressing challenging molecules, and a reduced time-to-clinic for a wide range of complex modalities. With more than 60 world-wide collaborations with pharmaceutical organizations over the last twenty years, our deep institutional knowledge and unmatched capabilities bring significant value to your product development program. Consider Pelican your experienced partner in expression optimization and the CMC arm for your organization as you prepare for entering the clinic and beyond.
In pursuit of our vision, we have also created a portfolio of therapeutics, produced by our patented Pelican Expression Technology™ platform, many of which include biosimilars and biobetters. Many of these candidates have been developed through Phase I clinical trials and are available for license.
Please contact firstname.lastname@example.org to request more information to engage Pelican as your trusted drug development partner.